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The eﬃcacy of catheter-based ablation techniques to treat atrial ﬁbrillation is limited not only by recurrences of this arrhythmia
but also, and not less importantly, by new-onset organized atrial tachycardias. The incidence of such tachycardias depends on
the type and duration of the baseline atrial ﬁbrillation and specially on the ablation technique which was used during the index
procedure. It has been repeatedly reported that the more extensive the left atrial surface ablated, the higher the incidence of
organized atrial tachycardias. The exact origin of the pathologic substrate of these trachycardias is not fully understood and
may result from the interaction between preexistent regions with abnormal electrical properties and the new ones resultant from
radiofrequency delivery. From a clinical point of view these atrial tachycardias tend to remit after a variable time but in some cases
areresponsibleforsigniﬁcantsymptoms.Apreciseknowledgeofthemostfrequenttypesofthesearrhythmias,oftheirmechanisms
and components is necessary for a thorough electrophysiologic characterization if a new ablation procedure is required.
1.Introduction
Organized atrial tachycardias (AT) are a common problem
after atrial ﬁbrillation (AF) ablation (post-AF ablation AT—
PAFAT). Since the ﬁrst isolated case reports [1–5], several
mechanisms [6] and diﬀerent times of onset following
the index procedure have been reported. A new ablation
procedure often solves this arrhythmic problem [5, 7–14].
Nevertheless, this rhythm disorder merits a special attention
for diﬀerent reasons: (1) it has a high incidence and is
often very symptomatic, (2) the complexity of the atrial
arrhythmogenic substrate, which may be responsible for the
frequent concurrence of several types of AT mechanisms in
the same patient, (3) the variety of mapping and ablation
approaches which have been reported and (4) the fact that
PAFATs mechanisms may be linked to the mechanisms
responsible for AF maintenance.
This paper reviews the incidence, clinical presentation,
mechanisms, electrophysiological characterization and abla-
tion of PAFAT. Finally, a brief review of organized ATs
presentingduringtheAFablationprocedureisalsoprovided.
2. Incidence
The real incidence of PAFAT cannot be easily extracted
from published series because most of them either focused
just on left [15–17]o rm a c r o r e e n t r a n t( M R )A T[ 18, 19],
or did not report the incidence of cavotricuspid isthmus-
dependent (CTI) atrial ﬂutter, which is responsible for 7–
10% [20–22] of all PAFATs. This latter ﬁgure is even higher
in patients with previous cardiac surgery [23]. In addition,
the reported incidence of PAFAT is probably underestimated
in most of these series because only symptomatic patients
were referred for a new ablation procedure [21, 24]. All these
reasons explain in part that the reported incidence of sus-
tained PAFAT varies widely. However, diﬀerences in PAFAT
incidence mainly depend on the following two factors: the
predominant type of AF before the index procedure and the
approach [8, 12, 13] used for AF ablation.
TheincidenceofPAFATrangesbetween4.7and31%and
is usually higher after circumferential pulmonary veins (PV)
ablation using wide-area circular lesions around ipsilateral
PVs (circumferential pulmonary vein ablation—CPVA) [25]2 Cardiology Research and Practice
or when additional ablation lines are incorporated in the
procedure than with other ablation approaches [15–18, 20,
21, 24, 26, 27]. This group of patients whose AF was
treated with CPVA is by far the one in which PAFATs have
been most extensively studied. However, several variants of
the original CPVA technique have been reported in recent
years. Abatement of PV electrograms within the encircled
area was the main endpoint of the original series and PV
electrical isolation (PVI) has been required only in the most
recent ones [26–28]. Despite this evolution [29], the PAFAT
incidence apparently has remained apparently unchanged.
The number and location of additional ablation lines had
been also heterogeneus among the diﬀerent reported series
but it seems that additional lines may have a greater impact
on PAFAT incidence than on AF recurrences. Pappone et al.
[25] and Anousheh et al. [27] found that by adding roof,
posterior, or mitral isthmus ablation lines the development
of new-onset macroreentrant AT was reduced in comparison
to CPVA alone, as far as conduction block across these lines
was achieved.
The incidence of AT is much lower after less extensive
AF ablation approaches such as segmental ostial PVI [1, 30,
31] or circumferential antral PVI [32], especially when no
additional ablation lines are used or only the electrically
active PVs are targeted [23, 24, 33–39]. The incidence of
AT with these latter approaches ranges between 2% and
7.7%.Theonlydiscrepantincidencevaluewiththisapproach
is the 29% found by Ouyang et al. [38] but that one
could have been related to the modiﬁcation of the standard
PV isolation technique which these investigators used. The
lower incidence of PAFAT found following segmental ostial
PVI could be partially related to the smaller proportion
of patients enrolled with persistent/chronic AF enrolled in
these studies, as opposed to the studies in which CPVA was
employed. Patients with long-standing persistent/chronic AF
have both more electrical and anatomical atrial remodeling
[40, 41] and low-voltage and scar areas [34] than patients
with paroxysmal AF. These scar areas have been associated
with MR circuits and may conﬁgure the substrate for orga-
nized AT [13, 34, 35]. This hypothesis was congruent with
a ninefold higher AT incidence in patients with persistent
forms of AF reported by Porter et al. (2,4% versus 20%)
[42]. Actually, this is not the case because the proportion
of patients with persistent/chronic AF in the studies in
which CPVA plus lines was used reached 17%–36,5% [15–
18, 20, 21, 24, 26, 27], a percentage similar to that reported
in the series in which segmental or circumferential antral
PV isolation was performed (8%–43%) [23, 24, 33–39]. As a
consequence,factorsdirectlylinkedtotheablationtechnique
in itself seem to determine the PAFAT incidence, although
the scarce studies that have compared both techniques have
yielded conﬂictive results [43, 44].
Finally,therearesomeotherstrategiesgloballycharacter-
izedbyanextensiveatrialablationwhichaimsatterminating
AF, rendering it noninducible or at least transforming it
into an organized AT amenable to mapping: complex frac-
tionated atrial electrograms (CFAEs) ablation [45], alone
or as an adjunct to PVI isolation, and stepwise approaches
comprising sequential addition of conventional techniques
[46]. The incidence of PAFAT in patients initially treated
with CFAE ablation alone or combined with PVI [45,
47–53] is 7,6%–24%, but Nademanee et al. published a
remarkable study with 674 patients in which a low incidence
of right atrial ﬂutter (2,4%) and no cases left AT [52]
were reported. Most of the patients included in these series
suﬀered persistent, permanent, or chronic AF (33%–100%).
On the other hand, a number of papers have reported the
incidence of AT after stepwise AF ablation or addressed
speciﬁcally AT appearing after these approaches [46, 53–59];
the incidence of PAFAT in this context oscillates between
23%–44%. Stepwise techniques are resorted to for long-
lasting persistent forms of AF almost exclusively (23%–100%
of patients in these series).
3.ClinicalAspects
From a clinical point of view, PAFATs are characterized
by: early onset after the index procedure, multiplicity of
arrhythmia types in the same patient (not always rec-
ognizable on the surface ECG), frequent and important
symptoms refractory to management with rate-controlling
drugs, limited amenability with antiarrhythmic drugs, high
recurrence rate after cardioversion, and to sum up, very
frequent requirement of at least one subsequent ablation
procedure to cure them.
3.1. AT Time of Onset after AF Ablation. Chang et al. [28]
demonstrated that multiple ATs can be induced in 16,3%
of patients immediately after circumferential PVI isolation,
and this proportion rises (38%) when a more extensive
ablation is used [19]. In other cases, an organized AT of
a“ t o t a l l y ”d i ﬀerent nature such as typical CTI-dependent
ﬂutter appears during AF ablation [60]. These ﬁndings
suggest that the substrate capable of maintaining organized
ATs is already present at this stage. It may explain why the
onset of AT occurs relatively early in the follow-up after
AF ablation, with an average time of onset between 2, 7–13
weeks [15–19, 55]. Ouyang et al. [38] and Themistoklakis et
al. [35] reported that more than 80% of the ATs they studied
had appeared during the ﬁrst 2 and 4 weeks after the AF
ablation procedure, respectively.
3.2. Clinical Course. Chugh et al. [18]p r o p o s e dt or e s e r v e
a new ablation for patients in whom the AT eventually
persists symptomatic after a prudential observation period,
because according to their reported experience, up to a
third of patients presented complete resolutions of their
ATs (spontaneously or after electrical cardioversion) and
an additional 4.7% achieved good clinical control under
pharmacologic treatment alone. This cautious proceed is
further guaranteed because in other studies, with diﬀerent
AF ablation techniques, 45–64% of patients remained free of
AT recurrences after a few months had elapsed [15, 17, 19,
45].
Although PAFATs are most commonly persistent (78%
[59]–92% [56]) instead of paroxysmal, they tend to cause
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studied by Pappone et al. [17]). Commonly, PAFAT are
more problematic for patients than the original AF, specially
because organized atrial arrhythmias are usually associated
to faster ventricular response thus requiring electrical car-
dioversion more frequently [15, 19, 20]. In addition, these
PAFATs respond poorly to antiarrthythmic drugs (only 4.7%
[22]–18% [20] of patients on antiarrhytmics are oligosymp-
tomatic enough as to reject a new ablation procedure),
and in some cases interruption of antiarrhythmics could be
beneﬁcial to avoid recurrences [33].
3.3. Multiple Diﬀerent Arrhythmias in the Same Patient. This
isoneofthemostprominentfeaturesofPAFAT.Ha¨ ıssaguerre
et al. [56] and Deisenhofer et al. [15] described 70–81% of
their patients to have more than one arrhythmia mechanism
during the electrophysiologic study. Other authors [15, 19,
57,58,61]havereportedthattheaveragenumberofdiﬀerent
AT mechanisms per patient varies between 1.8 ± 1.2 and 3.4
± 2.4 and that, in subsequent recurrences, the clinical AT is
diﬀerent to the original one in 79% of cases [21].
3.4. Predictive Factors of AT Occurrence. Several circum-
stanceshavebeenpostulatedtocontributetoamoreelevated
risk of PAFAT: extensive ablation [21, 24, 26], incompletely
ablated areas [15, 27, 62], PV reconnection [34, 38], early
debut of atrial arrhythmias post AF ablation [18, 21, 35, 63],
and previous long-lasting AF [17, 35]. Extensive ablation
may increase the incidence of AT both directly, creating con-
duction barriers that eventually would deﬁne and stabilize a
reentry circuit spatially separated from the ablated area [21,
64], and indirectly, enhancing the probability of conduction
gaps [17], sometimes with complex tridimensional structure
[65].
4. Typesof PAFAT
4.1. Macroreentrant Circuits after AF Ablation (Figure 1)
4.1.1. Frequency and Types. Macroreentrant (MR) ATs are
considered the most frequent arrhythmias after AF ablation,
comprising 57%–91% of the total. Nevertheless, some rele-
vant studies have made clear that it may not always be so.
Ha¨ ıssagerre et al. [56] and Deisenhoﬀer et al. [15]r e p o r t e d
that the so-called small-loop or localized reentry could be as
frequent a mechanism as MR. Shah et al. [37], Ouyang et
al. [38] and Gerstenfeld et al. [33] published data according
to which focal or small-loop reentry was the most frequent
mechanism (77%, 88%, and 100%, resp.). These striking
diﬀerences could reﬂect not only, in the ﬁrst instance, a
renewed interest in a more detailed characterization of
the frequently neglected “focal” atrial tachycardias [66–
68], but also the possibility that more limited ablation
strategies such as those used in these studies (PV segmental
or circumferential isolation alone [33, 37, 38]) are not so
liable to cause MR tachycardias. Perimitral atrial ﬂutter
is the most common type of MR circuit arising after AF
ablation (39%–61%), closely followed by roof-related or
peri-PV tachycardias (9%–61%), typical right atrial ﬂutter
- Mechanism: gap-relatedand non-gap-related.
- Associated to conduction gaps in ablation lines.
- Associated to very slow conducting areas.
Reconnected pulmonary veins.
. Triggered activity or abnormal automaticity
- Main types: perimitral, roof-dependant, peri
pulmonary veins, typical atrial ﬂutter, dual-loop
circuits.
A: Macroreentrant AT
d B: Small-loop/localize
reentrant AT
C: Pulmonary vein AT
D: Genuine focal AT 
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(15%, although in some case series this was the most
frequent arrhythmia [45, 52]), and other circuits involving
the coronary sinus (5%–7%), the interatrial septum (10%–
18%), or the anterior atrial wall [64]( 3 % )[ 15–21, 33, 37–
39, 45, 52, 54, 56, 57, 62, 69]. It is noteworthy that complex
dual-loop circuits are not rare (22%–55%) [16, 21].
4.1.2. Identiﬁcation and Mapping of MR Circuits. This mech-
anism is suspected when the activation sequence map yields
results congruent with a sequentially continuous electrical
activity accounting for at least 80%–90% of the tachycardia
cycle length (CL). Activation sequence maps are usually
obtainedwithtridimensional(3D)electroanatomicmapping
systems in which every local activation time is represented
as a color of a continuous spectrum, thus creating a visual
representation of the sequence of activation. If the diameter
of the circuit is ≥3cm, the earliest activated area is close
to the latest one (the typical “early meets late” or “head
meets tail” aspect), and if the range of local activation times
encompasses most of the CL, macroreentry is probable. The
boundaries delimiting the circuit (such as sites harboring
double potentials separated ≥50ms, low-voltage areas char-
acterized by voltages ≤0,05–1mV, anatomical obstacles) are
commonly included in the activation map representation
in order to depict the course of the activation front with
more anatomical accuracy. This method of creating an
activation sequence map was the most frequently used
in the studies previously cited. In spite of its widespread
acceptation, activation maps can be sometimes misleading
[56, 70] and lead to equivocal results. Typically, when the
entire MR circuit is not accessible or some parts of the
activation sequence cannot be registered with certainty [36,
71],theactivationmapofaMRcircuitcanbemisinterpreted
as an apparent centrifugal activation of the atria with a
presumptive, but false, focal origin [36]. The limitations4 Cardiology Research and Practice
of the activation mapping are posed by a nonsystematic
collection of points during which critical areas of the circuit
[72] may be missed, the intrinsic diﬃculty of assigning
an objectively exact activation time to a multicomponent
or low-voltage fractionated electrogram, and the presence
of multiple areas of slow conduction or conduction block
resulting in an abnormally prolonged time to complete LA
activation [73]i ns u c haw a yt h a ts o m ea t r i a la r e a sa r e
activated very late. Some modiﬁcations of the conventional
point-by-point construction of activation maps have been
attempted in order to simplify the approach and gain
accuracy. For example, the use of multielectrode catheters
[72] or the elegant reﬁnement of this technique reported by
De Ponti et al. [74].
In addition, the documentation of a sequential atrial
activation through the entire AT cycle length is insuﬃcient
to establish the existence of an atrial MR arrhytmia: the only
unequivocal proof is the demonstration of fusion during
entrainment or, what is even more compelling, return cycles
after entrainment matching the tachycardia CL from at
least two distant sites. In this respect, entrainment mapping
with fusion aﬀords the ultimate evidence of a reentrant
mechanism irrespective of the “focal” appearance of the
activation map [33, 36, 39, 71]. A detailed analysis of
entrainment maps has not been carried out in most studies:
in some cases entrainment techniques have been used [16,
19, 20, 28, 34, 75] only exceptionally, and in other cases
entrainment has been used in a limited way just to conﬁrm
that certain sites of interest (particularly putative isthmuses
candidate for ablation) belong to the circuit [17, 21, 22,
58, 62, 72]. On the other hand, entrainment mapping has
been used by some investigators in a more comprehensive
manner to determine the true spatial location of the circuit
[15, 36, 57, 64]. Some authors have manifested a certain
reluctanceagainstanexhaustiveuseofentrainmentmapping
[76] not only because of its limitations (it is not always
possible to demonstrate fusion, specially when reentrant
circuitsaresmall[37])butalsobecausethereexistapotential
risk of terminating the AT into sinus rhythm, a diﬀerent AT
or AF.
4.2. Focal Mechanisms (Figure 1)
4.2.1. Deﬁnition and Types. The identiﬁcation of a focal AT
[6] is based on two criteria: (a) centrifugal spread of the
activation front in all directions from the site of earliest atrial
activation [75], (b) range of activation duration less than
the AT CL [16, 17], or in other words, sequential electrical
activity accounting for less than 80%–90% of the CL [21,
22]. However, it is sometimes very diﬃcult to discriminate
between reentrant and focal mechanisms [36, 56], specially
in a previously ablated atria. Due to this diﬃc u l t y ,an u m b e r
of subordinate criteria have been proposed to suspect a
focal origin [6, 33, 53, 57, 68]: (a) CL variations >10%,
(b) discrete P-waves with clear isoelectric intervals between
them, (c) inconsistent return cycles after entrainment pacing
from several locations, (d) identical P wave and atrial
activation sequence during pacing at the focus site and
during the clinical AT, and (e) QS wave on the monopolar
lead located on the origin of the AT. It must be noted that a
focal origin of the electrical activation does not necessarily
involve a “genuine” focal mechanism, such as enhanced
automaticity or triggered activity. In this regard, it might
be useful to remember that any confusion of terminology
must be avoided: the term “focal AT” refers primarily to a
pattern of concentric activation from a focus/source [6], the
mechanism of which could indistinctly consist on (micro)
reentry, abnormal automaticity, or triggered activity. In
consequence, the use of the term “focal” as a synonym for
automatic or triggered mechanism is confuse [6].
Ap a r t i c u l a rs u b g r o u po ff o c a lA T s[ 77]a r ec h a r a c t e r -
ized by (a) adenosine insensitivity (they present neither
termination nor transient suppression), (b) low-amplitude
potentials at the focus site, (c) long-duration electrograms
(spanning a great portion of the cycle length) at the origin
site, and (d) a response to overdrive pacing consistent with
entrainment. All these features, considered together, strongly
advocate reentry as the underlying mechanism. Sanders et
al. [68] studied 27 tachycardias with a catheter specially
designed for high-density mapping, establishing a localized
reentry mechanism in 8 of them. The most relevant ﬁnding
of this approach was the indisputable demonstration of
sequential electrical activity during 95.2 ± 4.5% of the CL,
together with prolonged fractionated electrograms at the
sites of origin. Takahashi et al. [55] achieved similar results
usingconventionalactivationandentrainmentmapping,but
they also measured the size of the circuit (always <2cm), the
width of the isthmus (variable between <5 and 10mm) and
conﬁrmedthespatialrelationshipofthesesmall-loopreentry
circuits to previously ablated areas. The close relationship
between low-voltage zones (LVZs) or scar areas and the
site of origin of the focal AT was reassured by Higa et
al. [67] using noncontact mapping. Surrounding LVZs can
sometimes conﬁgure a preferential exit channel from the
AT focus [78]. These microreentry or small-loop reentry
circuitsfairlyexplainwhyMohamedetal.[79]demonstrated
that the closer to the AT focus the entrainment site is
located, the shorter is the return cycle minus CL diﬀerence,
a type of response that suggest a reentrant circuit when can
be obtained consistently [80]. Finally, such sites harboring
localized reentrant circuits have been directly proved or
strongly proposed to be involved in the maintenance of AF
[81, 82].
Deisenhofer et al. [15]h a v ed i ﬀerentiated two types
of small-loop reentry circuits (<3cm) on the basis of
a very reasonable argumentation: (a) small-loop reentry
circuits related to gaps on previous ablation lines and (b)
small-loop reentry circuits related to areas with markedly
slow conduction, generally located in close proximity to
previously ablated areas but not related to conduction gaps.
Schematic small-loop reentry circuits resultant from the
modiﬁcation of a previous arrhythmogenic substrate by
radiofrequency lesions were hypothesized by Merino in 2006
[73].
The other two focal mechanisms (automaticity and
triggered activity) have not been so well deﬁned in patients
presenting PAFAT and would remain an exclusion diagnosisCardiology Research and Practice 5
when MR or localized reentrant circuits could not be con-
ﬁrmed. Their typical responses to adenosine and overdrive
pacing along with their typical clinical presentation as
repetitive burst of tachycardia can serve as clues to suspect
the diagnosis [77, 83].
4.2.2. Frequency and Preferential Locations. In general, focal
ATs constitute a minoritary group. For example, Deisenhofer
et al. [15] did not report any focal ATs in their series, but
it must be noted that 31% of the PAFATs they studied
were too unstable for complete characterization. Gerstenfeld
et al. [33], on the other hand, initially attributed a focal
mechanism to all PAFATs they found after segmentary
PVI. This assumption was somewhat doubtful because all
these tachycardias manifested a fused intracardiac activation
sequence during entrainment. On the basis of entrainment
maneuvers the same authors published a second report [39]
in which only one of ﬁve PAFATs had a presumable pure
focal mechanism and the other four cases were small-loop
reentries. These results underscore the capital importance of
the diﬀerentiation between a focal activation pattern and a
true focal mechanism. The ﬁrst one habitually results from
small-loop reentries or conduction barriers which can mask
a MR mechanism [34, 73].
Rostock et al. [57], Chae et al. [21], and Mesas et al. [16]
published a prevalence of focal AT which varies between 12–
28%ofthetotalPAFATs.Theimmensemajorityofthesefocal
PAFATs were found near the PV antra in close relationship
to previously ablated areas (41–100%) [16, 21, 57]. Apart
from this preferential location, PAFATs with a conﬁrmed
or putative focal mechanism have been described as being
scattered in many other places such as the coronary sinus
(23%), interatrial septum (11-12%), LA roof and LA inferior
wall [21, 57].
5.Electrophysiologic Characterization
of PAFAT
A precise knowledge of the arrhythmogenic substrate as well
as a great familiarity with the electrophysiologic properties
of AT circuits is essential to identify and ablate their critical
components.
5.1. Conduction Gaps. Conduction gaps are simply narrow
parcels of surviving cardiac tissue still capable of eﬀective
electrical conduction which connect two zones otherwise
separated by an interposed area of nonconducting tissue.
This area of conduction block generally consists on scar
tissuecausedbyradiofrequencyorothermodalitiesofenergy
delivered for ablation. Therefore, a gap is always a portion
of cardiac muscle which has been either reversibly damaged
by the ablation catheter, independently of the nature and
intensity of the lesion (inﬂammation, edema, alteration of
membraneproperties[84])ornotdamagedatall.Obviously,
gapscanbealreadypresentimmediatelyaftertheAFablation
procedure. These residual gaps are typical in atrial regions
which are hardly accessible to radiofrequency energy for
whateverreason:catheterinstability,edemaformation,tissue
thickness that prevents the transmurality of the lesions, or
tricky anatomical areas such as the ridge between the left
upper pulmonary vein and the left atrial appendage [17, 85,
86]. More frequently, however, conduction gaps appear later
as true “reconnections” [87] of the previously ablated areas.
5.1.1. Relationship between Gaps and PAFAT. Despite mul-
tiple targeted radiofrequency applications during an AF
ablation procedure, multiple or single gaps can persist in a
signiﬁcant number of patients (5–19%) [17, 88, 89]. These
incomplete lines have been proved to be a strong promoting
factor of AT [17, 27, 43]. The extreme examples of this
cause-eﬀect relationship are exempliﬁed by some published
cases of (a) acute organization of AF into a MR AT gaps
located in ablation lines which have been deployed just a
few minutes before [75] and (b) gap-dependent MR ATs
which can be induced shortly after apparently complete PV
circumferential isolation [60]. The reason most frequently
adduced to explain the presence of conduction gaps is
immediate or delayed conduction recovery. Certainly, this
is the only acceptable hypothesis when PV isolation and
bidirectional conduction block across other additional lines
was reliably conﬁrmed [16–18, 62, 89]p r e v i o u s l y .
In turn, gap-related macroreentry is the most habitual
type of MR PAFAT (65%–96%) [16, 21, 28, 58, 62, 89]
and multiple gaps are habitually required [36, 71, 73].
In addition, a relevant proportion of focal or small-loop
reentrant ATs have also been found spatially related to single
(100% of focal AT reported by Mesas et al. [16] and Luik et
al. [60]) or double gaps (35% of small-loop reentry reported
by Deisenhofer et al. [15]). Pure PV tachycardias [73]a f t e r
AF ablation as those published by Ouyang et al. [38]d e s e r v e
a particular comment because they are a direct consequence
of PV reconnections through gaps.
5.1.2. Identiﬁcation of Gaps. Conduction gaps are viable
tissue surrounded by permanent lesions; in consequence,
they are located in incompletely ablated areas which can
be revealed by magnetic resonance image techniques due
to the presence of preserved atrial muscle bundles. It has
been demonstrated that up to a maximum of 20% of the
surface of the tissue where radiofrequency has been applied
( a r e a su s u a l l ym a r k e db yl e s i o nd o t so nt h e3 Dn a v i g a t i o n
systems) may correspond to viable tissue (not aﬀected by
gadolinium late-enhancement) [90] .T od a t e ,h o w e v e r ,t h e
eﬃcacy of this approach to detect very small bundles of
viable atrial myocytes has not been validated. An indirect
way to suspect the presence of conduction gaps in ablation
linesisthesimultaneousachievementofATinterruptionand
bidirectionalblockacrossthelineusingasingleorafewfocal
radiofrequency applications [38]. A detailed activation map
can oﬀer a more direct proof of the participation of gaps
in a MR circuit when the activation front traverses perpen-
dicularly the place where a prior ablation line was created
[21,60].TheexactpositionofablationlinesrelativetotheAT
circuit can be checked by side-by-side comparison of the AT
activation map and the tridimensional reconstruction of the
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techniques of image integration implemented in modern 3D
navigation systems, which allow for a more exact delineation
of the spatial relationship between incomplete ablation lines
and the circuit of the AT [91]. The most direct evidence
which identiﬁes a conduction gap is the presence of a single
potential ﬂanked by double potentials. The single potential
(frequently fractionated) corresponds to the viable muscle
and the double potentials to the ablation line lying at both
sides of the gap [16].
5.1.3. Conduction Properties of Gaps. Noncontact mapping
technology has provided greatly detailed images of the
activation wavefront propagation across an ablation line
through a gap: the activation front narrows upon reaching
the gap and widens again at the other side of the line
[92]. However, electrical conduction through discontinuous
ablation lesions is a complex phenomenon inﬂuenced by
the width of the gap, its geometry, and possibly the time
elapsed since the lesions were created. In this sense, certain
experimental models suggests that there is a minimum
width necessary for gaps to conduct (habitually 3mm [93]).
Besides, the gap size can modulate the conduction velocity
of the wavefront crossing it, in such a way that the narrower
the gap, the slower the conduction velocity [93]. As a result,
small gaps are usually characterized by long-duration and
very fractionated potentials small gaps usually showing [93–
95]. The overall delay is not exceedingly great in comparison
to normal tissue [94] and has been deemed to lack clinical
relevance, insofar as small gaps are still capable of relatively
fast conduction [38]. The solid results of Melby et al.
[95]r e a ﬃrm both ideas: only very small gaps tend to
manifest features of slow conduction (as a matter of fact,
fragmentedelectrogramsareaprominentdistinctivemarkof
conduction gaps in the clinical setting [16, 38, 58]), and the
overallconductionvelocity impairment is small,allowingfor
eﬀective conduction of very rapid paced rhythms and even
AF.
Ontheotherhand,conductionpropertiesofgapsdepend
not only on their width but also on their geometrical con-
ﬁguration: angled or “L-” shaped gaps are much less likely
to conduct than bifurcarted (“Y-” shaped) or straight gaps
[65]. In general, sodium-channel blockers are eﬀective in
preventing gap-related electrical conduction in experimental
models [65].
5.1.4.FrequentLocationsofGaps. Rostocketal.[87]reported
the distribution of sites of conduction recovery in roof lines
and mitral isthmus lines: 66% of gaps in the mitral isthmus
line were localized in the upper portion, close to the left
inferior pulmonary vein and the left atrial appendage; 54%
of gaps in the roof line were found in close relation to the
rightsuperiorpulmonaryveinostium.Bothpreferentialsites
are the result of anatomical structures that condition a worse
stability of the catheter and areas of greater wall thickness
more diﬃcult to ablate with transmural lesions. Similarly,
Mesas et al. [16] found also a preferential location of gaps
near the septum and the superior segment of the lateral left
atrium, in both cases around the PV antra. Chang et al. [60]
reported that the preferential location was another diﬃcult
place: the left atrial appendage ridge. However, Ouygang
et al. [38] did not ﬁnd any preferential distribution for 32
conductiongapsincircumferentiallinesaroundthePVostia,
in spite of the fact that gaps were approximately twice as
frequent around the left PV.
5.2. Critical Isthmus
5.2.1. Anatomic Description. An isthmus can be deﬁned as
the narrowest part of the circuit. This deﬁnition involves
two elements which need a precise characterization. Firstly,
the course of the activation front deﬁned as entirely as
possible by the middle of activation mapping, entrainment
mapping, noncontact mapping or analogous techniques;
secondly, the presence of conduction barriers delimiting the
anatomic channel through which the activation front tra-
verses. These boundaries can be normal anatomic structures,
scar areas, areas of conduction block (double potentials)
[96], or previously ablated areas. Ja¨ ıs et al. [97] published an
interesting study in which they identiﬁed critical isthmuses
on the basis of an exclusively anatomic concept: an isthmus
is conﬁgured by two lateral barriers and a corridor of
normally excitable atrial tissue between them. These authors
also demonstrated that a line of ablation transecting these
isthmi is an adequate therapy for most macroreentrant AT.
Obviously, this approach can be resorted to if the ATs
is not stable enough as to resist a detailed entrainment
mapping [98] and the participation of the isthmus in the
circuitcanbedemonstratedatleastwithactivationmapping.
However, Ouyang et al. [99] showed with conclusive data
that isthmi are usually narrow and the typical electrograms
registered within them are of very low voltage amplitude
(generally <0.5mV) and multicomponent or fragmented. As
a result, isochronal and activation maps are specially limited
to characterize them, because it is often really diﬃcult to
assign a reliable local activation time to such low-voltage
andfragmentedelectrograms.Furthermore,purelyanatomic
isthmi are not always the feeblest part of the circuit. For
example,theso-calledmitralisthmuscanbespeciallydiﬃcult
to block bidirectionally [27], and this diﬃculty has led some
authors to propose an alternative approach: the “anterior (or
superior) line”. This line, traced from the mitral annulus to
either superior PV, blocks the entire anterior aspect of the
left atrium [100, 101].
5.2.2. The Critical Isthmus from a Functional Point of View.
De Ponti et al. [74] introduced a simple and elegant reﬁne-
ment of the conventional colour-coded activation map as a
tool to help localize the zone of “diastolic” activation of the
circuit. This strategy consists in a speciﬁc parameters setting
of the 3D navigation system such that the location of the
transition “purple-red” or “purple-white” (the traditional
point where “head meets tail”) limit identiﬁes the position
of the diastolic isthmus, which, in comparison to the systolic
isthmus, is more frequently characterized by low-amplitude
potentials and slow conduction [74] and corresponds almost
always to the most vulnerable part of the circuit.Cardiology Research and Practice 7
Entrainment mapping, in turn, is the most consistent
method to determine whether a given point in the atrium
belongs to the circuit or not [102, 103]. Isthmi can be
deﬁned with mere entrainment criteria [104] as those
areas presenting concealed entrainment (deﬁned as identical
P-wave morphology and intra-atrial activation sequence
duringpacingandduringAT),ﬁrstpostpacing intervalequal
to AT CL and a delay between the stimulus artifact and
the elicited activation front of at least 40msec. It seems
clear, therefore, that activation mapping and entrainment
mapping are complementary strategies [105] to localize the
circuit and its course, boundaries, isthmi, slow-conduction
areas, and, specially, sites where ablation has more chances
to be eﬀective, as Bogun et al. [104] studied in an excellent
work only limited by the low number of cases included.
Being it so, the true critical isthmus is not only a narrow
corridor anatomically deﬁned, but, above all, a site where
the tachycardia is interrupted and rendered noninducible
with the minimal number of radiofrequency applications.
These sites hold some ancillary features which contribute to
theiridentiﬁcation:longactivationtimes,splitorfragmented
electrograms, diastolic potentials and matching stimulus P-
wave and electrogram P-wave intervals [104].
In the particular setting of PAFAT, isthmi can be consti-
tuted merely by gaps or by the interaction between ablated
areas, preexisting scar areas and anatomic structures. Both
an exclusive anatomical approach [15, 16, 18, 21, 22], and a
more functional [17, 37, 61] characterization have been used
to detect isthmi under those circumstances.
5.3. Low-Voltage Areas and Slow-Conduction Zones
5.3.1. Preexisting and Iatrogenic Scar Zones and Areas of
Slow Conduction. Whereas patchy ﬁbrosis and increased
concentration of type I collagen have been observed in
patients with lone paroxismal AF [106], signiﬁcant scar
areas (characterized by very low voltage, ≤0,1mV) have
not been described in this group of patients [107]. Some
authors have postulated the origin of abnormal atrial zones
(LVZs, slow-conduction and scar areas) to be either totally
iatrogenicortheresultoftheinteractionbetweenincomplete
radiofrequency lesions and speciﬁc anatomic structures (lig-
ament of Marshall, autonomic ganglia) [58, 108]. However,
thereareimportantcumulativedatasupportingtheexistence
of these abnormal areas independently of radiofrequency
lesions. Taclas et al. [90] noticed that late gadolinium
enhancement was sometimes detectable in locations where
radiofrequency had not been applied. Moreno-Reviriego
et al. [109] demonstrated the presence of a dense scar
(characterized by absence of capture at maximal paced
impulse output) or low-voltage area in 10 of 16 patients with
persistent/long lasting FA. Verma et al. [110]d e t e c t e ds c a r
areasin6%ofAFpatientsanddemonstratedtheroleofthese
areas as independent predictors of AF recurrences. Lo et al.
[41] investigated the progressive decrease in the mean LA
voltage and increase in the extension of low-voltage zones
(subtracted the contribution of ablated areas) in patients
with AF recurrences after PVI. Lin et al. [111] evaluated the
role of areas characterized by functional conduction block
and low voltage in delimiting slow-conduction isthmi as a
common mechanism for right atrial ﬂutter and ﬁbrillation.
Cummings et al. [34] appreciated that preexisting scar areas
may act as an additional substrate for PAFAT because PV
reisolation alone was less eﬃcacious to prevent recurrences
in patients with scar areas than in those without them. Ja¨ ıs
et al. [64] found that some ﬂutter circuits were constituted
by areas of slow conduction distant from PV ostia and not
targeted by prior ablation. Yoshida et al. [62]c o n c l u d e d
that radiofrequency lesions cannot be directly linked to
at least 30% of AT that appear late after AF ablation
because these tachycardias were not adjacent to ablation
sites. In addition, as previously discussed, there is still a lack
of demonstrative evidence that slow conduction could be
attributed to RF lesions. For example, in spite of the complex
conduction properties manifested by partially ablated areas,
slow conduction was ruled out by Chorro et al. [112] as the
mechanismoftheprolongedconductiontimemeasurednear
radiofrequency lesions because it could be always explained
by the conduction detour of the wavefront around the
lesion. Besides, it remains without explanation why RF is
specially (or exclusively) prone to beget slow conduction and
iatrogenic arrhythmias in the LA and not in other substrates
such as ventricular scars or RA ﬂutters [73].
5.3.2. Scars, Low-Voltage Zones, Slow-Conduction Areas, and
Atrial Tachycardias. Independently of their origin, these
abnormal areas may play a role in PAFAT for several reasons.
First of all, LVZs are an integral part of the critical isthmus
of most ATs. Secondly, LVZs and scars can simply make
up the lateral boundaries delimiting a MR circuit, as is
the case when a perimitral ﬂutter is induced immediately
after circumferential PVI [60] or after linear ablation at the
roof, perhaps because the circuit is conﬁned within these
barriers and stabilized preventing short circuiting [21]. This
constraining eﬀect of natural and iatrogenic lateral barriers
is most probably necessary for the maintenance of circuits
unrelated to ablated zones [64]. There exist a more intricate
cause-eﬀect relation between areas of slow conduction and
small-looporlocalizedreentrantAT, becausewhenreentrant
circuits are small in size, the phenomenon of slow electrical
conduction acquires its most crucial relevance. Typically,
small-loop reentrant circuits appear near previous ablation
lesions and in places to which a special relevance for AF
maintenance is commonly assigned, such as the PV antra
[16, 21, 37] or the LAA opening [15, 46, 113]. The critical
component of these circuits is a narrow isthmus showing
typical low-amplitude fractionated electrograms which span
a great part of the CL, indicating slow conduction [37].
In the most extreme examples [15] fractionated potentials
lasting up to 140ms and occupying 60% of the TCL or
even the entirety of the CL can be registered [68, 81].
Deisenhoﬀer et al. [15] revealed something as important
as frequently neglected: very slow-conduction areas are not
located across ablation lines, on the contrary, they are
simply adjacent to them. Consequently, it is reasonable
to hypothesize that, if these slow-conduction areas existed8 Cardiology Research and Practice
before radiofrequency applications, they could have served
as substrate for small and very rapidly rotating circuits
implicated in the maintenance of AF. Posteriorly, RF lines
could have modiﬁed the electrical properties of the circuit,
for example, increasing its size and CL. The ﬁnal result
would be the creation of the mechanism of organized ATs
as a consequence of the interaction between a previous
abnormal substrate responsible for AF maintenance and
radiofrequency lesions [73].
5.4. PV Reconnection and PV-Related Triggering Foci. PV-
related foci of ectopic activity implicated in AF initiation
and maintenance seem to play a relevant role in triggering
organized PAFAT, although the participation of extra PV
triggers should not be underestimated.
As noted before, PVI is the only element of all the
AF ablation techniques clearly associated with a reduced
incidence of PAFAT. After AF ablation, the persistence of
PVI is also fundamental for sinus rhythm maintenance.
The most relevant piece of evidence was provided by the
great proportion of patients in whom PV reconnection
was demonstrated during the PAFAT study and ablation.
Ouyang et al. [38]a n dC h u ne ta l .[ 114] addressed the
problem of PV reconnection in both case series of PAFAT
after catheter-guided PVI and surgical Maze, respectively.
Their results were incontrovertible: 80% of patients with
AT recurrences after catheter ablation and 88% of patients
with AT after Maze procedure presented PV reconnection.
Similarly, according to a recent study by Sy et al. [115], in
the group of patients requiring a second ablation procedure
after PVI (48.3% presented recurrences in form of organized
PAFAT), 82% of the PV were reconnected. Other authors
[33, 34, 36, 39] have also indirectly proved the cause-eﬀect
relation between the presence of venoatrial reconnections
and PAFAT. In addition, the contribution of ectopic activity
arising from the PV to the initiation of organized AT is also
proved by the capital importance of PV reisolation to reduce
ATrecurrences.Forexample,Cummingsetal.[34]evaluat ed
theeﬀectofPVreisolationalonetotreatLAﬂuttersfollowing
a previous PVI procedure and obtained interesting results:
61% of patients remained free of arrhythmia recurrences oﬀ
antiarrhythmics and an additional 21% on antiarrhythmics.
The importance of abolishing the contribution of PV-related
triggers was reported by Wazni et al. [116] as well. Patients
with coexistent AF and typical right atrial ﬂutter were
included in this study and underwent PVI isolation without
concomitant bidirectional cavotricuspid isthmus blockade,
which was curative in most of them. Therefore, in the light
of all these data PV reconnection remains the milestone
of the pathologic process which ultimately leads to PAFAT
occurrence, to such an extent that a certain dependence of
organized AT on PV triggering foci has to be assumed. The
question is whether this relationship is direct or indirect,
or in other words, whether PV ectopics are able to initiate
organized AT with or without an intermediate period of AF
[116, 117]. Both possibilities are likely but it must be noted
that, in a simulation study, Gong et al. [118] demonstrated
that the atria are more vulnerable to premature beats arising
from the PVs than from other locations and that the
vulnerable window for atrial ﬂutter/AF induction (the range
of diﬀerent pacing CL and extrastimuli coupling intervals)
is markedly smaller for right atrial foci in comparison to PV
foci.
Two reasonable consequences can be drawn from the
close relationship between PV reconnection and PAFAT.
Firstly, PV reisolation should be considered the ﬁrst pro-
cedural step when a PAFAT ablation is undertaken [14].
Secondly, all measures aiming at reducing the risk of PV
reconnection have to be implemented. For example, it is
commonly reckoned today that a mere anatomic atrial
ablation guided by electroanatomic mapping systems is
unreliable in achieving a complete PVI [24, 119]. Conse-
quently, PVI should be assessed routinely by a circular-
mapping-guided catheter approach, taking into account that
critical areas such as the carina between ipsilateral veins have
to be targeted for ablation almost always [120]. Finally, many
laboratories have adopted the use of general anesthesia for
AF ablation procedures in view of the lower probability of
PV reconnection reported by Di Biase et al. [121]o rh a v e
started to employ magnetic robotic navigation [122, 123].
This new technology has been suggested to improve the
catheter stability or to simplify the PVI technique.
6. Results of Ablation
In the previous paragraphs we have enumerated the great
number of strategies which have been published to localize
and characterize the mechanism of PAFAT. All of them
should be considered complementary approaches, and their
use should be conditioned to the operator experience and
to the particular requirements and peculiarities of each AT
in an individualized manner. Basically, our experience and
the published results of other authors invite to consider that
activation mapping should always be complemented with
entrainment maneouvres and that the tridimensional image
support aﬀorded by electroanatomic navigation systems is
in general advisable to optimize the results of ablation. The
algorithm proposed by Knecht et al. [14] and developed
by Ja¨ ıs et al. [61] deserves the utmost attention because
it provides accurate rules to elucidate the most frequent
PAFAT mechanisms laying emphasis on simple and precise
criteria: PVI reisolation is performed ﬁrst and then focal,
macro-reentrant, and small-loop reentrant mechanisms are
systematically sought after in this order.
In spite of the heterogeneity of techniques habitually
resorted and the diﬀerences in the degree of mechanistic
characterization of these arrhythmias, several authors have
published convincing results (see Table 1) showing the
success rate of PAFAT invasive treatment. The clinical PAFAT
can be ablated almost always (70–100% of individual AT).
Patel et al. [72] and Deisenhoﬀer et al. [15]r e p o r t e da
somewhat lower percentage of success (61% and 38%, resp.)
which may be explained because most of their patients
presented several diﬀerent ATs. However, recurrences of
new organized ATs are not rare (up to 21%–44%). Long-
term sinus rhythm maintenance has not been convenientlyCardiology Research and Practice 9
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explored by the studies summarized in Table 1 because the
time of fol-lowup after the PAFAT treatment was not long
enough in most cases.
7.OrganizedAT duringAF Ablation
AF termination is considered by some authors a desiderate
but not always attainable objective of AF ablation. The
distillation [14] of AF into organized AT has been judged a
reasonable way to modify the substrate responsible for AF
maintenance. However, the extensive ablation this objective
usually demands, together with the controversial results
which have apparently disproved its eﬃcacy in terms of
eﬀective prevention of AF recurrences [124], has precluded
a more widespread acceptation of this opinion. At all events,
organization of AF into AT during ablation is an interesting
phenomenon, worthy of mention because it has given rise to
new hypothesis about AF maintenance mechanisms. Some
of these organized ATs are not spontaneous. For example,
Chang et al. [28] induced organized AT in 16.3% of patients
immediately after circumferential PVI, most of them (76%)
weregap-relatedATandmacro-reentrantcircuitsaroundthe
mitral annulus or ipsilateral PVs were the most frequent.
In fact, this inducibility guided strategy may be helpful to
uncover gaps and latent AT circuits which could eventually
acquire clinical relevance afterwards [18]. On the other
hand, spontaneous ATs have much more interest from a
mechanistic point of view because they could indicate the
location of areas relevant for AF maintenance. Scharf et al.
studied six cases of spontaneous conversion of AF into focal
AT during left atrial ablation. All these ATs had a focal origin
adjacent to ablated areas but unrelated to conduction gaps,
and what is even more important, three of them had also
an exact spatial correspondence with areas that seemed to
anchor the fastest frequencies during AF (characterized by a
CLduringAF30–40msshorterthanthemeanCLinadjacent
zones). These focal sources of organized AT were correctly
interpreted as slowed versions of very rapidly ﬁring zones,
the mechanism which had been probably modiﬁed by the
ablation procedure. Only one of them manifested the typical
behavior of an automatic focus but the mechanism was not
investigated in great detail in the rest. A further and not less
excitinginsightintothehypothesisthatAFandorganizedAT
couldbetwosidesofthesamecoinwasprovidedbythestudy
of Yoshida et al. [62] In this study the AF ablation strategy
consisted in antral PVI and targeting of complex fraction-
ated electrograms until AF converted to sinus rhythm or
organized AT. There was a spectral component in the AF
periodogram that matched the frequency of the resulting AT
in 52% of patients who presented acute transformation of
AF into AT. This proportion was higher (79%) when the AF
preriodogram was evaluated just before conversion to AT.
This correspondence between the frequency of the resulting
AT and one of the components of the AF periodogram
suggests that the AT circuit is already present during AF
in some way or another, but hidden behind the ﬁbrillatory
proccess and surpassed by the higher-frequency components
of the AF spectrum of frequencies. As for the mechanism
of these resulting ATs, 94% were macro- or micro-reentry
circuits, 70% of them located distant from the ablated areas.
How crucial is the contribution of these lower-frequency
drivers to the global ﬁbrillatory phenomenon? It is evident
that the lower-frequency components alone cannot result in
ﬁbrillatory activity once the higher-frequency components
have been abolished. Nevertheless, it is not known whether
the ﬁbrillatory process requires not only the high-frequency
drivers to be manifest but also the lower-frequency reentrant
circuits to remain stable or what would happen if these
subordinate components could be localized and ablated
independently in the ﬁrst instance.
Organization of AF into AT during extensive CAFEs
ablation occurs in 36% of cases of paroxysmal AF and in
50% of persistent AF [125]. Diﬀerent mechanisms of AT in
this context were described in pioneer works [46]a n dh a v e
been recently revisited by Nam et al. [53], who have reported
the following results: 30% perimitral MR, 30% cavotricuspid
isthmus-dependent ﬂutter, 18% roof-dependent MR, 18%
focal and 6% of unknown mechanism. These circuits are
well-known, amenable to mapping, and commonly ablated
indailyclinicalpractice,fromwhencecomestheopinionthat
AForganizationmightbeasgoodanoutcomeastermination
[61].
8. Conclusions
The incidence of PAFAT is clinically relevant but depends
on the ablation technique initially used to treat AF and
on the existence of appropriate anatomic substrates, which
sometimes exist before the ablation procedure. Both the
mechanisms and elements constitutive of PAFAT circuits
are well-known and have been repeatedly and consistently
described. This fact, along with the high probability of
success when these AT are targeted for ablation, and the
low eﬃcacy of antiarrhytmic drugs, implies that an invasive
approach should be attempted if these AT became incessant,
bad tolerated or do not disappear after a prudential obser-
vation period. However, it must be noted that the frequent
coexistence of multiple mechanisms and several diﬀerent
types of PAFAT in the same patient determine the special
complexity of these procedures, in which PV reisolation is
the pivotal element when reconnection has occurred.
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